Announcements Trials
Browse Landscape

Status

Recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Dermatologic 1

Conditions

Clinical Stage III Cutaneous Melanoma AJCC v8 1

Interventions

pembrolizumab 58Cyclophosphamide 53Ipilimumab 52Nivolumab 44aldesleukin 35Interleukin-2 26fludarabine phosphate 22fludarabine 21Vemurafenib 20Temozolomide 19Radiotherapy 18dabrafenib 15trametinib 12Radiosurgery 11CTLA-4 Antigen 11Filgrastim 10Dacarbazine 10spartalizumab 9cobimetinib 9binimetinib 9atezolizumab 9Biopsy 9poly ICLC 8Paclitaxel 8Antilymphocyte Serum 8encorafenib 7avelumab 7Rituximab 7Introns 7romidepsin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Absorptiometry, Photon × Dermatologic × Clear all
NCT04516122 2025-08-17

Bone Loss in Melanoma Survivors Receiving Immunotherapy

M.D. Anderson Cancer Center

Terminated
12 enrolled
Dermatologic

Clinical Stage III Cutaneous Melanoma AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡